Simplex Trading, LLC Zynerba Pharmaceuticals, Inc. Transaction History

Simplex Trading, LLC

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Apr 27, 2023	SELL	$0.4 - $0.67 $557 - $933	-1,393 Reduced 37.99%	2,274 $0
Q4 2022 Feb 02, 2023	BUY	$0.5 - $0.72 $1,833 - $2,640	3,667 New	3,667 $1,000
Q2 2022 Aug 03, 2022	SELL	$0.86 - $2.06 $843 - $2,020	-981 Closed	0 $0
Q1 2022 May 02, 2022	BUY	$1.83 - $3.02 $1,795 - $2,962	981 New	981 $2,000
Q3 2020 Oct 14, 2020	SELL	$3.23 - $4.3 $32,978 - $43,903	-10,210 Closed	0 $0
Q2 2020 Jul 13, 2020	BUY	$3.31 - $6.54 $33,795 - $66,773	10,210 New	10,210 $0
Q2 2019 Jul 26, 2019	SELL	$5.4 - $15.5 $10,740 - $30,829	-1,989 Closed	0 $0
Q1 2019 Apr 18, 2019	SELL	$3.6 - $6.22 $5,508 - $9,516	-1,530 Reduced 43.48%	1,989 $0
Q4 2018 Jan 16, 2019	SELL	$2.89 - $7.91 $6,424 - $17,583	-2,223 Reduced 38.71%	3,519 $10,000
Q3 2018 Oct 23, 2018	BUY	$5.59 - $10.45 $32,097 - $60,003	5,742 New	5,742 $46,000
Q2 2018 Jul 30, 2018	SELL	$7.98 - $12.39 $25,711 - $39,920	-3,222 Closed	0 $0
Q1 2018 Apr 26, 2018	BUY	$8.49 - $13.46 $22,566 - $35,776	2,658 Added 471.28%	3,222 $27,000
Q4 2017 Jan 10, 2018	SELL	$8.69 - $14.59 $21,420 - $35,964	-2,465 Reduced 81.38%	564 $7,000
Q3 2017 Oct 25, 2017	BUY	$5.73 - $9.44 $17,356 - $28,593	3,029	3,029 $25,000

774K

Ticker ZYNE
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 45,753,100
Description
Zynerba Pharmaceuticals, Inc. operates as a clinical stage specialty pharmaceutical company. The company focuses on developing pharmaceutically-produced transdermal cannabinoid therapies for rare and near-rare neuropsychiatric disorders. It is developing Zygel, a pharmaceutically-produced cannabidiol formulated as a permeation-enhanced gel for t...

Get notified when there are updates to the investment portfolio of Simplex Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Simplex Trading, LLC with notifications on news.